Citation Impact
Citing Papers
Electrolyte levels and net fluid and electrolyte movements in the gastrointestinal tract of weanling swine.
1977
Pathophysiological study of diarrhoea in a patient with medullary thyroid carcinoma. Evidence against a secretory mechanism and for the role of shortened colonic transit time.
1988
Differential Serum Levels of Eosinophilic Eotaxins in Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, and Autoimmune Hepatitis
2013 StandoutNobel
Regulatory T-cell directed therapies in liver diseases
2013 StandoutNobel
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
2000 Standout
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
2003 Standout
Sjögren's syndrome
2005 Standout
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Histological grading and staging of chronic hepatitis
1995 Standout
Liver fibrosis – from bench to bedside
2003 Standout
Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
1988 Standout
Nonalcoholic Fatty Liver Disease
2002 Standout
Guidelines on Bladder Cancer
2002
Diagnosis and treatment of autoimmune hepatitis
2002
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease
2001
Diagnosis and Management of Autoimmune Hepatitis
2010
SMOOTH MUSCLE AND THE SURGEON
1989
Autoimmune hepatitis
2011
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†
1996
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
An Algorithm for the Grading of Activity in Chronic Hepatitis C
1996 Standout
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Chronic hepatitis B
2007 Standout
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
1999 Standout
The nomenclature of chronic active hepatitis: An obituary
1993
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Nonalcoholic fatty liver disease
2005 Standout
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
2002 Standout
Natural history of liver fibrosis progression in patients with chronic hepatitis C
1997 Standout
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Early enteral feeding versus “nil by mouth” after gastrointestinal surgery: systematic review and meta-analysis of controlled trials
2001 Standout
Cutaneous Vasculitis in Primary Sjögren Syndrome
2004
Prognosis and life expectancy in chronic liver disease
1995
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Radioimmunoassay in Gastroenterology
1972 StandoutNobel
Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients With Chronic Hepatitis C
1994 Standout
Immunoblotting and dot immunobinding — Current status and outlook
1984 Standout
Circulating IgG complexes in primary biliary cirrhosis. A serial study in forty patients followed for two years.
1978
Prognostic value of spontaneous hyponatremia in cirrhosis with ascites
1976
Characterization of antigen moiety of HBsAg in the complement fixing immune complexes of hepatitis B virus positive chronic active hepatitis.
1982
Primary Biliary Cirrhosis
1987 Standout
Prediction of Drug Absorption Using Multivariate Statistics
2000 Standout
INHIBITION OF GASTRIN AND GASTRIC-ACID SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONE
1974 StandoutNobel
A review of unusual systemic manifestations associated with carcinoma
1964
Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines
1983 Standout
Hypersecretion of Gastrin Associated with the Short Bowel Syndrome
1974 StandoutNobel
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-α2b
1993 StandoutNobel
Studies on the Distribution and Degradation of Heptadecapeptide, Big, and Big Big Gastrin
1974 StandoutNobel
The aetiology and management of ascites in patients with hepatic cirrhosis: A review
1963
Additional Studies on the Nature of Big Big Gastrin
1973 StandoutNobel
Functional properties of anthocyanins and betalains in plants, food, and in human nutrition
2003 Standout
Human Jejunal Effective Permeability and Its Correlation with Preclinical Drug Absorption Models
1997
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
The syndrome of inappropriate secretion of antidiuretic hormone
1967 Standout
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†
1981 Standout
Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C
2004 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Chronic active hepatitis
1980
Progress report. Radioimmunoassay of intestinal hormones.
1974
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Classification of chronic hepatitis: Diagnosis, grading and staging
1994 Standout
A physiological approach for preparing and conducting intestinal bioavailability studies using experimental systems
2002
Elevation of serum xanthine oxidase activity following halothane anesthesia in man
1977
Works of Summerskill Wh being referenced
Occlusion of the jejunum for intestinal perfusion in man.
1966
Intractable peptic ulcer in hereditary endocrine-ulcer disease: "gastrin" content of endocrine tissues.
1961
Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.
1972
Pathogenesis and treatment of disorders of water and electrolyte metabolism in hepatic disease.
1960
Hepatic function tests: postoperative changes with halothane or diethyl ether anesthesia.
1966
Failure of customary treatment in chronic active liver disease: causes and management.
1976
Treatment of "refractory" ascites with a new aldosterone antagonist in patients with cirrhosis.
1960
Classification and treatment of chronic active liver disease.
1968
Alpha1-antitrypsin phenotypes in chronic active liver disease and primary biliary cirrhosis.
1976
Radioimmunoassay of porcine cholecystokinin-pancreozymin.
1971
Water and electrolyte transport during maintenance of isotonicity in human jejunum and ileum.
1967
SJOEGREN'S SYNDROME.
1964